BARD1 and cancer: Therefore, the presence of point mutations in BARD1, or deletion-bearing or truncated BARD1 isoforms, generated by alternative splicing of mature mRNA transcripts or by the use of multiple translation start sites (TSS), respectively, might significantly affect its functions, leading to cancer development.